The morbidity associated with scorpion sting intoxication presents an endemic pattern in the country, where there are highly venomous species of scorpions so the scorpion sting intoxication (IPPA) is considered a medical emergency. On the other hand, there is scarce scientific literature from different controlled studies evaluating anti-scorpion serum, considering clinical severity scales, lab results and their safety. The aim of this study is to compare the efficacy and safety of scorpion sting treatment, using two sera, one produced by Birmex versus Alacramyn ® (Bioclon).
We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem. This is a randomized clinical trial, which included 120 subjects of both sexes aged 0 and 15 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum (Alacramyn).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
TRIPLE
Enrollment
120
the dose may be required for the patient according to clinical manifestations and evolution
The dose may be required fot the patient according to clinical manifestations and evolution
Hospital General Regional de León
León, Guanajuato, Mexico
Resolution of signs and symptoms of scorpion envenomation
Time frame: after treatment (expected average of 12 hrs)
Evaluate the adverse events in every treated child
Time frame: inmediately after treatment and until 5 days later
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.